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Abstract: 
Background: The readmission rate for neonatal jaundice has been increased in 
recent years. This has been attributed to shorter length of postpartum hospital 
stays without comprehensive follow-up. The purpose of this study was to 
determine the diagnostic value of pre-discharge transcutaneous bilirubin (TcB) 
levels for prediction of subsequent hyperbilirubinemia in healthy term 
neonates.  
Methods: Between October and December 2013, a total of 99 healthy term 
neonates born at the Babol Clinic Hospital of healthy mother were enrolled in a 
prospective cross sectional study. The TcB levels were measured in all enrolled 
neonates between 12 and 24 hours of age just before discharge. All newborns 
were followed-up for jaundice to 10th day. Newborns with clinical jaundice 
were recalled and their serum bilirubin levels were measured. Appropriate 
treatment was performed based on the Amirkola Children's Hospital Protocol. 
TcB levels were compared between the non-treatment and treatment groups. 
Results: The mean age of the TcB measuring was 17.5±2.6 hours. A total of 
18.1% neonates (18 of 99) were developed severe hyperbilirubinemia (need for 
treatment). The mean of cutaneous bilirubin level in the non-treatment and 
treatment groups was 5.2±1.6mg/dl and 6.3±0.9 mg/dl, respectively. The 
cutaneous bilirubin level at cut-off 6 mg/dl was associated with 80.0% 
sensitivity and 63.0% specificity. The negative predictive value was 94.6%. 
Conclusion: Single TcB measurements at the first 24 hours predict 
hyperbilirubinemia with a reasonably high degree of accuracy. 
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Introduction: 
Approximately 60% of all neonates will develop clinical jaundice 
[1]. 
Hyperbilirubi-nemia is still the most common cause of neonatal readmission to 
hospital in North America. Despite efforts to identify neonates at risk of 
hyperbilirubinemia, readmission rate has increased in the United States and 
Canada due to implementing early hospital discharge of neonates since 1999. 
Jaundice is the most common cause of readmissions in discharged neonates 
who are healthy otherwise 
[2]
. Different methods have been used to predict 
jaundice, so that routine measuring of serum bilirubin level before discharge is 
the best 
[3]
. Although measuring serum bilirubin level is the gold standard to 
evaluate bilirubin level, causing pain stress, sampling area infection, requiring 
laboratory and taking more time in comparison with Tc bilirubinometry caused 
more using of Tc bilirubinometry 
[4]
. In the other side, early hospital discharge 
of neonates revealed necessity of using Tc bilirubino-metry. First 
bilirubinometer was applied in 1980; it still couldn’t take measuring serum 
bilirubin level’s place 30 years afterwards [5].  
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Tc bilirunometry which could significantly reduce 
serum-sampling rates was considered as an effective 
help in different studies 
[6]
.  
In our country (Iran) the value of using Tc 
bilirubinometry seems more due to a large number of 
patients, which causes neonates discharge earlier than 
world standards, besides measuring serum bilirubin 
level is being done by venous sampling instead of 
capillary sampling. The present study was performed in 
order to implement and evaluate the power of Tc 
bilirubinometry to predict severe neonatal jaundice 
(treatment required for jaundice). 
 
 
Methods: 
This cross-sectional prospective study was 
performed at Babol Clinic hospital in Babol city from 
October to December 2013. One hundred five healthy 
neonates with Apgar score [8-10] and birth weight over 
2500 gr without anomaly, born from healthy mothers 
were enrolled in this study.  
The exclusion criteria were as follows:  
1) Hospitalization due to conditions other than 
jaundice,  
2) Occurrence of other diseases during the follow-up,  
3) Lack of access to infants and  
4) Hospitalization before measuring TCB. Six neonates 
were excluded (3 neonates due to incompleted 
documents, 3 neonates due to unavailability). Ninety 
nine neonates were followed up.  
All of them were discharged in less than 24 hours of 
birth date while their Tc bilirubin was measured by 
Bilicheck (David-JH 201A, China) and their 
demographic information was recorded according to 
that right before discharge. Neonatal follow up for 
jaundice continued to 10
th
 day. Neonates with clinical 
jaundice after measuring serum bilirubin level received 
appropriate treatment from therapeutic physicians to 
control the disease and they were referred to Amirkola 
Children's Hospital to be treated according to its 
therapeutic protocol if it was needed (table 1).  
Neonates stratified in two groups: Those who needed 
treatment as treatment group and the rest as non-
treatment group. The collected data of these two groups 
were analyzed by SPSS 22, t-test statistical tests and 
Pearson correlation coefficient and using ROC curve 
and achieving area under appropriate cross point of 
curve. 
 
 
Results: 
A total of 99 neonates participated in this study, 
51(51.5%) and 48(48.5%) neonates were female and 
male, respectively. All neonates who needed treatment, 
treated by UV light treatment (phototherapy). Mean 
gestational age was 38.70±0.60 weeks and the mean 
neonatal birth weight was 3643.87±426.94 gr. The age 
of neonates at Tc bilirubinometry was between 12 and 
24 hours after birth (mean 17.53±2.64 hours). The 
mean cutaneous bilirubin level measured in studied 
neonates was 5.42±1.62 mg/dl (table 2).  
The mean cutaneous level of bilirubin in non-
treatment group including 81 neonates (81.81%) and in 
treatment group (according to therapeutic protocol of 
Amirkola Children's Hospital) including 18 neonates 
(18.18%) was 5.22±1.67 mg/dl and 6.32±0.91 mg/dl, 
respectively (P= 0.009) (table 3).  
Comparing ROC curves of cutaneous bilirubin level 
of treatment with non-treatment groups showed that 
cutaneous bilirubin level 6 mg/dl is the most 
appropriate cut-off to predict severe neonatal jaundice 
(treatment required for jaundice), which has 80% 
sensitivity and 63% specificity. Considering that 
therapeutic criteria of Amirkola Children's Hospital are 
lower than American Academy of pediatrics (AAP) 
criteria, we compared treatment-required neonates 
(according AAP guideline) with the rest of neonates. 9 
neonates (9.09%) required treatment according to AAP 
protocol.  
The mean cutaneous bilirubin level in this group 
was 6.68±0.50 mg/dl. Non-treatment group consisted 
of 90 neonates (90.90%) and mean cutaneous bilirubin 
level was 5.30±1.64 mg/dl (P= 0.014). Comparing 
ROC curves of cutaneous bilirubin level of treatment 
with non-treatment groups according to AAP guideline 
revealed that cutaneous bilirubin level 6 mg/dl is the 
most appropriate cut-off to predict severe neonatal 
jaundice (treatment required according to AAP) and 
has 100% sensitivity. 
Table 1: Amirkola Children's Hospital therapeutic protocol for neonatal jaundice treatment in healthy term neonates [12] 
Day1 Day 2 Day 3 Exchange Transfusion Discharge 
 (mg/dl)  With risk factor Without risk factor Age≥72hour 
TSB
*≥5 TSB≥10 TSB≥15 TSB≥20 mg/dl TSB≥25 mg/dl And TSB≤10 mg/dl 
* TSB=Total Serum Bilirubin 
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Table 2: Baseline demographic data for neonates (Mean±SD) 
Characteristics of Neonates N Minimum Maximum Mean Std. Deviation 
Maternal age(year) 99 17 40 28.72 4.54 
GA(w) 99 37.28 40.28 38.70 0.60 
W(gr) 98 2600 5000 3643.88 426.94 
Age at Tc bilirubinometry(hour) 99 12 24 17.54 2.65 
TCB
*
(mg/dl) 99 0.7 7.7 5.43 1.62 
TSB(mg/dl) 41 8.20 21 13.34 2.82 
*TCB=Transcutaneous Bilirubin 
 
 
Table 3: TCB level, P value in non-treatment and treatment groups based on Amirkola Children's Hospital 
therapeutic protocol for neonatal jaundice treatment in healthy term neonates (Mean±SD) 
 Group N Mean Std. Deviation P-value 
TCB 
Non-treatment 
Treatment 
81 
18 
5.23 
6.32 
1.68 
0.92 
0.009 
 
 
Table 4: TCB level, P value in non-treatment and treatment groups based on AAP guideline for neonatal 
jaundice treatment (Mean±SD) 
 Group N Mean Std. Deviation P-value 
TCB 
Non-treatment 
Treatment 
90 
9 
5.30 
6.69 
1.64 
0.51 
0.014 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure: 1. Receiver operating characteristic (ROC) 
curve of transcutaneous bilirubin (TCB) at the 
treatment group, based on Amirkola Children's 
Hospital protocol, area under the curve is 0.722 
Figure 2: Receiver operating characteristic (ROC) 
curve of transcutaneous bilirubin (TCB) at the 
treatment group, based on AAP protocols for treatment 
neonatal jaundice, area under the curve is 0.801 
 
Discussion: 
Results of the current study showed that measuring 
cutaneous bilirubin level between 12 and 24 hours after 
birth can predict severe neonatal jaundice (treatment 
required for jaundice) in first week with high 
sensitivity. Different methods have been used to 
predict neonatal jaundice such as measuring umbilical 
cord bilirubin level in a study performed by Bernaldo 
AJ in 2004, umbilical cord bilirubin level was 
considered and he concluded that if UC bilirubin level 
exceeds 2 mg/dl, 53% of neonates will require UV 
light treatment 
[7]
. 
In the study of Shahfarahat et al.’s in 2013, UC 
bilirubin level was considered as predictor of 
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pathologic hyperbilirubinemia. They found that there 
was significant statistical difference in UC bilirubin 
level between treatment group (bill>15 mg/dl) and non-
treatment group, and this test had 68.86% sensitivity 
and 61.18% specificity by considering UC bilirubin 
level at cut-off 2 mg/dl. The present study had 80% 
sensitivity and 63% specificity in predicting treatment 
required for jaundice (according to hospital protocol) 
preferred to measure UC bilirubin level regarding to 
expenses, ease of doing and sensitivity.  
In 2002, Sarici SU et al.’s conducted a study and 
they used serum bilirubin level of 6
th
 hour after birth as 
predictor of severe hyperbilirubinemia to determine 
hemolysis. According to acquired results, if bilirubin 
level of 6
th
 hour after birth is among 4 to 6 mg/dl, it 
will predicts almost all neonates who develop severe 
jaundice. In study performed by Alpay F and 
colleagues in 2000, they used measuring of first day 
bilirubin level as predictor of severe hyperbili-
rubinemia. Results showed that bilirubin level 6 mg/dl 
in first day of age predicted almost all neonates who 
would become very icteric and need UV light treatment 
[10]
.  
In our study, measuring cutaneous bilirubin level in 
first day had 100% sensitivity at cut-off 6 mg/dl 
(according to AAP guideline) preferred regarding to 
being non-invasive ease of doing. A study performed in 
the United States in order to evaluate cutaneous 
bilirubin level as predictor of jaundice showed that 
using bilirubin level at cut-off 75 percentile before 
discharge had 100% sensitivity and 88% specificity 
[11]
.  
In the current study cutaneous bilirubin level at cut-
off 6 mg/dl in first 24 hours after birth had 100% 
sensitivity and 60% specificity in predicting severe 
jaundice (treatment required for jaundice) according to 
AAP guideline. 
At present time because of a large number of 
patients, the neonates were discharged earlier than 
standard period in many of health care centers. In our 
country (Iran), hospital beds are not enough for a large 
number of patients, therefore very early neonatal 
discharge (less than 24 hours of admission) which 
occurs for most of neonates increases the readmission 
rate due to jaundice; thus, it is necessary to perform 
more evaluation on it, besides paying more attention to 
value of measuring cutaneous bilirubin level within 
first 24 hours after birth.  
Considering early neonatal discharge in our 
country, measuring cutaneous bilirubin level before 
discharge even in first day of age, predicts treatment 
required for jaundice in neonates with high sensitivity 
to make parents informed and warned. 
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